Pharmacists in Indianapolis, Indiana


1388 Pharmacists found in Indianapolis
female pharmacist

Yoonsoo Kim


Pharmacist
550 University Blvd, Indianapolis, IN 46202
765-714-8690    

female pharmacist

Miss Yvonne Irene Wince, RPH


Pharmacist
608 Twin Aire Dr, Indianapolis, IN 46203
317-264-1755     317-264-1756

male pharmacist

Zach Madere


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
8745 S Emerson Ave, Indianapolis, IN 46237
317-884-3325    



male pharmacist

Zachary Moon


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2001 W 86th St, Indianapolis, IN 46260
317-554-7760    

male pharmacist

Zachary J Snyder, PHARMD


Pharmacist
10202 E Washington St, Indianapolis, IN 46229
317-899-3793     317-899-3793

male pharmacist

Zachary William Howe, PHARMD


Pharmacist
1701 N Capitol Ave Rm B222, Indianapolis, IN 46202
636-614-6884    

male pharmacist

Zachary Tyrcha, PHARMD


Pharmacist
1550 E County Line Rd Ste 150, Indianapolis, IN 46227
317-534-6258    

male pharmacist

Zachary Ryan Ress, PHARMD


Pharmacist
3808 E Washington St, Indianapolis, IN 46201
317-357-5437    

male pharmacist

Mr. Zachary A Weber, PHARMD


Pharmacist
1001 W 10th St, Myers Building, W7555, Indianapolis, IN 46202
317-613-2315    

male pharmacist

Zachary Lee Bozarth, PHARMD


Pharmacist
9900 Westpoint Dr Ste 100, Indianapolis, IN 46256
317-841-0388    

female pharmacist

Ms. Zhuanqing Gong


Pharmacist
7506 N Shadeland Ave, Indianapolis, IN 46250
765-409-5649    

female pharmacist

Zoey Thu Tran, PHARMD


Pharmacist
6632 Furnas Rd, Indianapolis, IN 46221
317-480-6824    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.